We determined the serum concentrations of HBD2, HMGB-1, Claudin-3 and Relmβ by enzyme-linked immunosorbent assay (ELISA) and combined them with other clinical indicators to explore their predictive value in NEC surgery decision-making. The gene discussed is RETNLB; the disease is necrotizing enterocolitis.